Polymorphism Near the Interleukin-28B Gene and Anti-Hepatitis C Viral Response.

Authors:
Asahina Y; Nakagawa M; Kakinuma S; Watanabe M.

Journal:
J Clin Transl Hepatol

Publication Year: 2013

DOI:
10.14218/JCTH.2013.005XX

PMCID:
PMC4521272

PMID:
26357605

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Clin Transl Hepatol

Abbreviation: J Clin Transl Hepatol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Novel Algorithm for Streamlining Diagnosis of Advanced Liver Fibrosis in CHB Patients with Concur…
Xu X; Rui F; Ni W and 3 more (2024) - Transparency Score: 3/6
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis.
Gallo P; Flagiello V; Falcomatà A and 5 more (2024) - Transparency Score: 2/6
Focal Nodular Hyperplasia: A Comprehensive Review with a Particular Focus on Pathogenesis and Compl…
Villavicencio Kim J; Wu GY. (2024) - Transparency Score: 2/6
Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Ana…
Abboud Y; Ismail M; Khan H and 4 more (2024) - Transparency Score: 2/6
Improving the Conversion Success Rate of Hepatocellular Carcinoma: Focus on the Use of Combination …
Chen QF; Chen S; Chen M and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: Dr Asahina and Dr Kakinuma belong to a donation-funded department funded by Chugai Pharmaceutical Co., Ltd., Toray Industries, Inc., Bristol-Myers Squibb Company, Dainippon Sumitomo Pharma Co., Ltd., and MSD K.K."

Evidence found in paper:

"Conflict of interest: Dr Asahina and Dr Kakinuma belong to a donation-funded department funded by Chugai Pharmaceutical Co., Ltd., Toray Industries, Inc., Bristol-Myers Squibb Company, Dainippon Sumitomo Pharma Co., Ltd., and MSD K.K."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025